MTOR and systemic lupus erythematosus: In addition, increased NO in T-cells from lupus patients and mice contributes to the activation of mTOR and accumulation of mitochondria, promoting SLE disease activity (Nagy et al., 2003; Nagy et al., 2004; Fernandez et al., 2009).